Standard BioTools Inc.
Organization details
- Legal name
- Standard BioTools Inc.
- Former names
- Fluidigm Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- LAB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001162194
- EIN
- 77-0513190
Board of directors
-
Carlos Paya V · DirectorSince 2023
-
Eli Casdin · DirectorSince 2023
-
Fenel M. Eloi · DirectorSince 2023
-
Frank Witney · DirectorSince 2023
-
Kathy L. Hibbs · DirectorSince 2024
-
Laura Clague · DirectorSince 2023
- Since 2023
-
Michael Egholm · Director · President & CEOSince 2023
-
Thomas D. Carey · DirectorSince 2024
-
Troy Cox · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
91.2%
-
94.0%
-
94.6%
Board connections
7 of this board's directors also sit on 14 other boards. 8 are in the same sector.
- via Kathy L. Hibbs and Troy Cox
- via Fenel M. Eloi
- via Frank Witney
- via Martin D. Madaus
-
Cerus Corporation Same sectorvia Frank Witney
-
Collegium Pharmaceutical Inc. Same sectorvia Carlos Paya V
-
GeneDx Holdings Corp. Same sectorvia Eli Casdin
-
Haemonetics Corporation Same sectorvia Martin D. Madaus
-
MapLight Therapeutics Inc. Same sectorvia Troy Cox
- via Martin D. Madaus
-
Repligen Corporation Same sectorvia Martin D. Madaus
- via Frank Witney
-
Vaxcyte Inc. Same sectorvia Carlos Paya V
-
Zymeworks Inc. Same sectorvia Troy Cox
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $13,521,398
- 13 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Thomas D. Carey Director | Open-market purchase | +75,000 | $0.63 | $46,898 |
| Aug 20, 2026 | Michael Egholm Director, Officer (President & CEO) | Shares withheld for tax | −97,627 | $0.67 | $65,410 |
| Aug 20, 2026 | Kim Hanjoon Alex Officer (Chief Financial Officer) | Shares withheld for tax | −28,195 | $0.67 | $18,891 |
| Aug 20, 2026 | Mackay Sean Officer (SVP & Chief Business Officer) | Shares withheld for tax | −25,729 | $0.67 | $17,238 |
| Aug 3, 2026 | Michael Egholm Director, Officer (President & CEO) | Shares withheld for tax | −362,625 | $0.87 | $315,484 |
| Jul 23, 2026 | Kim Hanjoon Alex Officer (Chief Financial Officer) | Shares withheld for tax | −202,476 | $0.90 | $182,228 |
| Jun 20, 2026 | Mackay Sean Officer (SVP & Chief Business Officer) | Grant or award | +500,000 | — | — |
| Jun 18, 2026 | Thomas D. Carey Director | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | Frank Witney Director | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | Eli Casdin Director, 10% owner | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | Troy Cox Director | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | Fenel M. Eloi Director | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | Kathy L. Hibbs Director | Grant or award | +99,116 | — | — |
| May 20, 2026 | Kim Hanjoon Alex Officer (Chief Financial Officer) | Shares withheld for tax | −18,871 | $1.00 | $18,871 |
| May 20, 2026 | Mackay Sean Officer (SVP & Chief Business Officer) | Shares withheld for tax | −25,729 | $1.00 | $25,729 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Standard BioTools Inc.
Who is the CEO of Standard BioTools Inc.?
Michael Egholm is Standard BioTools Inc.'s President & CEO.
How many directors are on Standard BioTools Inc.'s board?
Standard BioTools Inc.'s board has 10 directors: Carlos Paya V, Eli Casdin, Fenel M. Eloi, Frank Witney, Kathy L. Hibbs, Laura Clague, Martin D. Madaus, Michael Egholm, Thomas D. Carey and Troy Cox.
Are Standard BioTools Inc. insiders buying or selling shares?
Over the last 12 months, Standard BioTools Inc. insiders bought $13.5 million of shares in 13 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="standard-biotools-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.